Mastoparan

General Information


DRACP ID  DRACP02655

Peptide Name   Mastoparan

Sequence  INLKALAALAKKIL

Sequence Length  14

UniProt ID  P01514 

PubChem CID  6324633 

Origin  Vespula lewisii

Type  Native peptide

Classification

  

Active ACP Cell-penetrating peptides Induce apoptosis



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
U-373MG Astrocytoma Carcinoma LD50=28.67 μM MTT assay 4 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial



Structure Information


PDB ID  1D7N  

Predicted Structure  DRACP02655

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C70H130N18O16

Absent amino acids  CDEFGHMPQRSTVWY

Common amino acids  AL

Mass  171201

Pl  11.1

Basic residues  3

Acidic residues  0

Hydrophobic residues  10

Net charge  3

Boman Index  1347

Hydrophobicity  115.71

Aliphatic Index  195.71

Half Life 
  Mammalian:
  Yeast:
  E.coli:

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22148546

Title  Enantiomer-specific bioactivities of peptidomimetic analogues of mastoparan and mitoparan: characterization of inverso mastoparan as a highly efficient cell penetrating peptide

Doi 10.1021/bc2002924

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.